Helicobacter pylori

Helicobacter spp. in gastrointestinal oncology

Microb Health Dis 2025; 7 : e1179
DOI: 10.26355/mhd_20253_1179

  Topic: Helicobacter pylori     Category:

Bures J.
Institute of Gastrointestinal Oncology, Military University Hospital Prague, Prague, Czech Republic
bures.jan@uvn.cz Close
, Kohoutova D.
Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic Close
, Zavoral M.
Institute of Gastrointestinal Oncology, Military University Hospital Prague, Prague, Czech Republic Close
, Voxova B.
Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic Close
, Ngo O.
Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic Close
, Pohnan R.
Department of Surgery, Charles University, Second Faculty of Medicine, Prague and Military University Hospital Prague, Prague, Czech Republic Close
, Majek O.
Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic Close
, Urbanek P.
Department of Medicine, Charles University, First Faculty of Medicine, Prague and Military University Hospital Prague, Prague, Czech Republic Close
, Petruzelka L.
Institute of Gastrointestinal Oncology, Military University Hospital Prague, Prague, Czech Republic Close
, Suchanek S.
Institute of Gastrointestinal Oncology, Military University Hospital Prague, Prague, Czech Republic Close

Loading

Helicobacter pylori infection recurrence in developed versus developing countries – a systematic review and meta-analysis

Microb Health Dis 2024; 6 : e1158
DOI: 10.26355/mhd_202411_1158

High altitude is associated with helicobacter pylori infection in a population of dyspeptic patients in Nepal – A research letter

Microb Health Dis 2024; 6 : e1113
DOI: 10.26355/mhd_20249_1113

  Topic: Helicobacter pylori     Category:

Trubshaw M.
MEDyARTE Foundation, Leatherhead, UK Close
, Yangchen Lama C.
MEDyARTE Foundation, Leatherhead, UK Close
, Bornschein J.
Medical Research Council Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK Close
, Trubshaw M. E.
MEDyARTE Foundation, Leatherhead, UK
michael.trubshaw@ndcn.ox.ac.uk Close

Loading

Gastric cancer – Clinical aspects

Microb Health Dis 2024; 6 : e1029
DOI: 10.26355/mhd_20249_1029

  Topic: Helicobacter pylori     Category:

Bornschein J.
Medical Research Council Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK
jan.bornschein@ndm.ox.ac.uk Close

Loading

Helicobacter pylori and the microbiome in gastric cancer development and treatment: A year in review

Microb Health Dis 2024; 6 : e1031
DOI: 10.26355/mhd_20249_1031

  Topic: Helicobacter pylori     Category:

Vieira P.
i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Barbedo-Tavares M.
i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Figueiredo C.
i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
cfigueiredo@i3s.up.pt Close

Loading

Current considerations on Helicobacter pylori infection in children: A comprehensive review of the available evidence

Microb Health Dis 2024; 6 : e1034
DOI: 10.26355/mhd_20249_1034

  Topic: Helicobacter pylori     Category:

Rogalidou M.
Division of Gastroenterology and Hepatology, First Department of Pediatrics, National and Kapodistrian University of Athens, Agia Sofia Children’s Hospital, Athens, Greece
rogalidoum@yahoo.com Close
, Papadopoulou A.
Division of Gastroenterology and Hepatology, First Department of Pediatrics, National and Kapodistrian University of Athens, Agia Sofia Children’s Hospital, Athens, Greece Close

Loading

Review – H. pylori and non-malignant diseases

Microb Health Dis 2024; 6 : e1036
DOI: 10.26355/mhd_20249_1036

  Topic: Helicobacter pylori     Category:

Bordin D. S.
A.S. Loginov Moscow Clinical Scientific Center, Moscow, Russia
dmitrybordin@gmail.com Close
, Livzan M. A.
Omsk State Medical University, Omsk, Russia Close
, Gaus O. V.
Omsk State Medical University, Omsk, Russia, Close
, Mozgovoi S. I.
Omsk State Medical University, Omsk, Russia Close

Loading

Review: trends in nanotherapeutics to manage Helicobacter pylori

Microb Health Dis 2024; 6 : e1038
DOI: 10.26355/mhd_20249_1038

  Topic: Helicobacter pylori     Category:

Chitas R.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Parreira P.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Martins M.C. L.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
cmartins@ineb.up.pt Close

Loading

Inflammation, immunity, and vaccines

Microb Health Dis 2024; 6 : e1040
DOI: 10.26355/mhd_20249_1040

  Topic: Helicobacter pylori     Category:

Gong R.
Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), Munich, Germany Close
, Gerhard M.
Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), Munich, Germany
markus.gerhard@tum.de Close

Loading

Gastric precancerous conditions or lesions and Helicobacter pylori

Microb Health Dis 2024; 6 : e1043
DOI: 10.26355/mhd_20249_1043

  Topic: Helicobacter pylori     Category:

Areia M
Gastroenterology Department, Portuguese Oncology Institute of Coimbra (IPO Coimbra), Coimbra, Portugal
miguel.areia75@gmail.com Close
, Dinis-Ribeiro M.
RISE@CI-IPO (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal Close

Loading

Helicobacter pylori: pathogenesis

Microb Health Dis 2024; 6 : e1046
DOI: 10.26355/mhd_20249_1046

  Topic: Helicobacter pylori     Category:

Sabanas P.
Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania
povilas.sabanas@lsmu.lt Close
, Jonaitis L.
Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania Close

Loading

Review: Helicobacter pylori and extragastric diseases

Microb Health Dis 2024; 6 : e1048
DOI: 10.26355/mhd_20249_1048

  Topic: Helicobacter pylori     Category:

Wizenty J.
Department of Hepatology and Gastroenterology, Charité – Universitätsmedizin Berlin, Berlin, Germany
jonas.wizenty@charite.de Close
, Sigal M.
Department of Hepatology and Gastroenterology, Charité – Universitätsmedizin Berlin, Berlin, Germany Close

Loading